S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Laboratorios Farmaceuticos Rovi (LABFF) Short Interest Ratio & Short Volume

C$86.05
0.00 (0.00%)
(As of 04/18/2024 ET)

Laboratorios Farmaceuticos Rovi Short Interest Data

Current Short Volume
400 shares
Previous Short Volume
900 shares
Change Vs. Previous Month
-55.56%
Dollar Volume Sold Short
$34,420.00
Short Interest Ratio / Days to Cover
0.0
Last Record Date
March 31, 2024
Today's Trading Volume
0 shares
Average Trading Volume
1,300 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Laboratorios Farmaceuticos Rovi ?

Sign up to receive the latest short interest report for Laboratorios Farmaceuticos Rovi and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LABFF Short Interest Over Time

LABFF Days to Cover Over Time

LABFF Percentage of Float Shorted Over Time

Laboratorios Farmaceuticos Rovi Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024400 shares C$34,420.00 -55.6%N/A0 $86.05
3/15/2024900 shares C$77,445.00 -35.7%N/A9 $86.05
2/29/20241,400 shares C$72,800.00 -30.0%N/A14 $52.00
2/15/20242,000 shares C$104,000.00 -9.1%N/A0 $52.00
1/15/2024600 shares C$31,200.00 No ChangeN/A0 $52.00
12/31/2023600 shares C$31,200.00 -33.3%N/A0 $52.00
12/15/2023900 shares C$46,800.00 +80.0%N/A0 $52.00
11/30/2023500 shares C$26,000.00 No ChangeN/A0 $52.00
11/15/2023500 shares C$26,000.00 +66.7%N/A0 $52.00
10/31/2023300 shares C$15,600.00 No ChangeN/A0.8 $52.00
10/15/2023300 shares C$16,239.00 No ChangeN/A0 $54.13
9/30/2023300 shares C$16,239.00 -25.0%N/A0 $54.13
9/15/2023400 shares C$21,652.00 -97.0%N/A4 $54.13
8/31/202313,100 shares C$666,528.00 -42.5%N/A0 $50.88
8/15/202322,800 shares C$1.16 million No ChangeN/A0 $50.88
7/31/202322,800 shares C$1.16 million +192.3%N/A228 $50.88
7/15/20237,800 shares C$398,580.00 +2,500.0%N/A0 $51.10
6/30/2023300 shares C$15,330.00 No ChangeN/A0 $51.10
4/30/2023900 shares C$45,990.00 -74.3%N/A0 $51.10
4/15/20233,500 shares C$178,850.00 No ChangeN/A0 $51.10
3/31/20233,500 shares C$178,850.00 -5.4%N/A0 $51.10
3/15/20233,700 shares C$189,070.00 +184.6%N/A0 $51.10
2/28/20231,300 shares C$66,430.00 No ChangeN/A0 $51.10
1/31/2023300 shares C$15,330.00 -50.0%N/A0 $51.10
1/15/2023600 shares C$30,660.00 -25.0%N/A0 $51.10
12/30/2022800 shares C$40,880.00 No ChangeN/A0 $51.10
12/15/2022800 shares C$40,880.00 -90.1%N/A1.3 $51.10
11/30/20228,100 shares C$413,910.00 -3.6%N/A0 $51.10
11/15/20228,400 shares C$429,240.00 +13.5%N/A0 $51.10
10/31/20227,400 shares C$378,140.00 No ChangeN/A74 $51.10
10/15/20227,400 shares C$378,140.00 No ChangeN/A0 $51.10
9/30/20227,400 shares C$378,140.00 -2.6%N/A0 $51.10
9/15/20227,600 shares C$388,360.00 +2,433.3%N/A0 $51.10
8/31/2022300 shares C$0.00 No ChangeN/A3 $0.00

LABFF Short Interest - Frequently Asked Questions

What is Laboratorios Farmaceuticos Rovi's current short interest?

Short interest is the volume of Laboratorios Farmaceuticos Rovi shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 400 shares of LABFF short. Learn More on Laboratorios Farmaceuticos Rovi's current short interest.

Is Laboratorios Farmaceuticos Rovi's short interest increasing or decreasing?

Laboratorios Farmaceuticos Rovi saw a drop in short interest in March. As of March 31st, there was short interest totaling 400 shares, a drop of 55.6% from the previous total of 900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Laboratorios Farmaceuticos Rovi stock?

Short selling LABFF is an investing strategy that aims to generate trading profit from Laboratorios Farmaceuticos Rovi as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Laboratorios Farmaceuticos Rovi?

A short squeeze for Laboratorios Farmaceuticos Rovi occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LABFF, which in turn drives the price of the stock up even further.

How often is Laboratorios Farmaceuticos Rovi's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LABFF, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:LABFF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners